Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss key adverse effects to watch and management strategies in EGFR-mutated NSCLC.
Stephanie J. McDonald, MSN, FNP-BC, AOCNP
Advertisement
Articles by Stephanie J. McDonald, MSN, FNP-BC, AOCNP
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss how nurse practitioners add valuable insight to treatment selection in EGFR-mutated NSCLC.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss communication strategies between specialists and patients in EGFR-mutated NSCLC management.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss initial conversations and methods of support for patients with EGFR-mutated NSCLC.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss how care providers help drive treatment adherence in EGFR-mutated NSCLC.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
2
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026
3
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
4
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
5